Above: AusBiotech chief executive Dr Anna Lavelle. Superannuation funds have been urged to offer more support to Australian biotechnology…
Above: AusBiotech chief executive Dr Anna Lavelle. Superannuation funds have been urged to offer more support to Australian biotechnology…
The Victorian Government’s $772 million investment in biotechnology has failed to produce any clear benefits due to a severe lack of strat…
